Status:
COMPLETED
Slovenian National COVID-19 Prevalence Study
Lead Sponsor:
University of Ljubljana
Conditions:
COVID-19
SARS-CoV-2
Eligibility:
All Genders
Brief Summary
The investigators are conducting a national COVID-19 prevalence survey on a sample of 3,000 inhabitants that were randomly selected from the Slovenian population. The sample is representative in age, ...
Detailed Description
The investigators are conducting a national COVID-19 prevalence survey on a sample of 3,000 inhabitants that we have randomly selected from the Slovenian population. The sample is representative in ag...
Eligibility Criteria
Inclusion
- Signed informed consent only.
Exclusion
- Declined participation, no response on study invitation, no samples collected.
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2020
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04376996
Start Date
April 20 2020
End Date
December 15 2020
Last Update
October 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Ljubljana
Ljubljana, Slovenia, 1000